Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03993509 · ClinicalTrials.gov registry record · NA

Effect of rTMS on Anxiety

A NA study of Anxiety and Fear, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
68
Enrollment target
1
Study location

NCT03993509 is a NA study of Anxiety and Fear that has completed, run by University of Pennsylvania. The registered enrollment target is 68 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03993509, a NA study of Anxiety and Fear, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
68 participants
Enrollment target
1
Study location

Study Summary

Given the overall lack of treatment adherence/efficacy, side effects of drugs, and the substantial burden of anxiety disorders on the individual and on the national healthcare system, there is a critical need for mechanistic research into the CNS mechanisms that underlie these disorders. Accordingly, the objective of this grant is to use noninvasive neuromodulation to causally identify the key neural mechanisms that mediate the cognitive symptoms of anxiety. This project is relevant to public health because it has the potential to lead to novel repetitive transcranial magnetic stimulation treatments for pathological anxiety.

Interventions

  • DEVICE rTMS to the right dlPFC

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2019-10-30
Est. Completion 2022-11-23
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT03993509

The ClinicalTrials.gov registry entry for NCT03993509 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (85% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which rTMS to the right dlPFC is the first listed.

NCT03993509 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03993509 about?

NCT03993509 is a clinical study titled "Effect of rTMS on Anxiety". Given the overall lack of treatment adherence/efficacy, side effects of drugs, and the substantial burden of anxiety disorders on the individual and on the national healthcare system, there is a critical need for mechanistic research into the CNS mechanisms that underlie these disorders. Accordingly...

What is the current status of trial NCT03993509?

This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2019-10-30. Estimated completion is 2022-11-23.

What conditions does trial NCT03993509 study?

This clinical trial studies the following conditions: Anxiety, Fear, Anxiety and Fear.

What interventions are being tested in trial NCT03993509?

The interventions under investigation include: rTMS to the right dlPFC (DEVICE).

Who is sponsoring clinical trial NCT03993509?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03993509 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.